logo conference-reports

Conference Reports

Educational funding by logo MSD Oncology

ESMO 2019 — Controversy — Should therapy be de-escalated in patients with HPV+ oropharyngeal cancer?

Cure rates in oropharyngeal cancer have gone up, but the quality of life in survivors is often compromised by dysphagia and other side effects.